Breaking News

Swiss National Bank Introduces Negative Interest Rate of -0.25%
Tweet TWEET

Popper and Company Announces Stephanie Kreml, M.D., As Newest Team Member

  Popper and Company Announces Stephanie Kreml, M.D., As Newest Team Member

- As Practicing Physician with Engineering Background, Dr. Kreml Brings Unique
Multi-Disciplinary Perspective to Helping Life Sciences Companies Address
Complex Business Challenges -

PR Newswire

BALTIMORE and AUSTIN, Texas, April 3, 2013

BALTIMORE and AUSTIN, Texas, April 3, 2013 /PRNewswire/ --Popper and Company,
an M&A advisory and specialty consulting firm to the life sciences industry,
announced today that Stephanie Kreml, M.D. has returned to the firm as
Principal. Dr. Kreml, who previously worked at Popper and Company from 2008 to
2010, has a broad career spanning clinical research, product engineering,
medical technologies, and commercialization strategy roles.

"We are thrilled to welcome back Stephanie to Popper and Company," said
Caroline Popper, M.D., M.P.H., the firm's Co-founder and President.
"Stephanie's medical background (she is a practicing physician) and technical
know-how as a trained engineer will be a tremendous asset to Popper and
Company's clients." Currently the firm has locations in Florida,
Baltimore/Washington, DC, Albuquerque, Toronto and Austin, and serves clients
worldwide – primarily in the diagnostics, device and digital health space.

In her role as Principal, Dr. Kreml will develop and implement business
strategy for start-up companies and new business units in existing companies;
consult in areas of clinical need, commercialization, and technology
assessment; perform due diligence for investment and acquisition targets in
the life science industry; critically evaluate unmet clinical needs and
technologies; and provide guidance to accelerate new production development
activities.

"After practicing medicine for the last few years, I return to Popper and
Company with a renewed vigor and excitement to pursue the intellectual
challenges of our assignments as we deliver results for our clients," said Dr.
Kreml. "With the rapid convergence of technology and medicine – and the rise
of digital health as an industry in its own rite – I can leverage my unique
perspective as a physician and an engineer to help life science companies
better address diverse healthcare issues."

From 2010 to 2013, Dr. Kreml held the positions of Associate Medical Director
and Center Medical Director at Concentra in Austin, Texas, and she continues
to practice as a staff physician part-time. Prior to medical school, she held
engineering positions with Motorola and Texas Instruments.

Dr. Kreml received her Doctor of Medicine from the Baylor College of Medicine
and a Bachelor of Science in Electrical Engineering from The University of
Texas at Austin. During her residency in general surgery, she was a research
fellow at Baylor College of Medicine's Human Genome Sequencing Center and in
the Mechatronics and Haptic Interfaces Lab at Rice University.

About Popper and Co.
Founded in 2003, Popper and Company is an M&A advisory and specialty
consulting firm whose mission is to help clients across the life sciences
spectrum – from public companies to private companies to investors – address
complex challenges, providing clients with unparalleled attention and, through
the deep domain expertise of its principals, creative and insightful advice.
The firm's operational background spans clinical, technology, marketing and
finance in a variety of capacities in the diagnostics, medical device and
pharmaceutical industries. The Popper and Company team delivers perspective,
value, and high-quality, hands-on service in the areas of business
development, mergers and acquisitions, strategic development, product
development, and diligence. Visit www.popperandco.com for more information.

SOURCE Popper and Co.

Website: http://www.popperandco.com
Contact: Jamie Lacey-Moreira, jamielacey@presscommpr.com, 410-299-3310
 
Press spacebar to pause and continue. Press esc to stop.